Literature DB >> 4358371

Search for BK and SV40 virus reactivation in renal transplant recipients.

K V Shah, R W Daniel, R F Zeigel, G P Murphy.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4358371

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  8 in total

1.  Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy.

Authors:  J M Reese; M Reissing; R W Daniel; K V Shah
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

Review 2.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.

Authors:  S D Gardner; E F MacKenzie; C Smith; A A Porter
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

4.  Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy.

Authors:  T F Hogan; B L Padgett; D L Walker; E C Borden; J A McBain
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

5.  Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia.

Authors:  A Corallini; G Barbanti-Brodano; M Portolani; P G Balboni; M P Grossi; L Possati; C Honorati; M La Placa; A Mazzoni; A Caputo; U Veronesi; S Orefice; G Cardinali
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

6.  Role of simian virus 40 in cancer incidence in solid organ transplant patients.

Authors:  V Paracchini; A Nanni Costa; S Garte; E Taioli
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

7.  The many faces of the anti-COVID immune response.

Authors:  Santosha A Vardhana; Jedd D Wolchok
Journal:  J Exp Med       Date:  2020-06-01       Impact factor: 14.307

8.  Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection.

Authors:  Bin Yang; Junpeng Fan; Jia Huang; Ensong Guo; Yu Fu; Si Liu; Rourou Xiao; Chen Liu; Funian Lu; Tianyu Qin; Chao He; Zizhuo Wang; Xu Qin; Dianxing Hu; Lixin You; Xi Li; Tian Wang; Peng Wu; Gang Chen; Jianfeng Zhou; Kezhen Li; Chaoyang Sun
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.